Medicine News and Research

RSS
Short people at greater risk of developing CVD or CHD compared to tall people: Review

Short people at greater risk of developing CVD or CHD compared to tall people: Review

Research findings hold promise for debilitating emotional symptoms of FXS

Research findings hold promise for debilitating emotional symptoms of FXS

CPAP therapy effective at recouping memory abilities impaired by obstructive sleep apnea

CPAP therapy effective at recouping memory abilities impaired by obstructive sleep apnea

Discovery Labs receives FDA guidance to gain Surfaxin approval for RDS in premature infants

Discovery Labs receives FDA guidance to gain Surfaxin approval for RDS in premature infants

Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems

Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems

Switching to healthier diet can slow or reverse cognitive impairment in patients with Alzheimer's Disease: Study

Switching to healthier diet can slow or reverse cognitive impairment in patients with Alzheimer's Disease: Study

Researchers look at exercise as new way to slow degenerative processes of ALS

Researchers look at exercise as new way to slow degenerative processes of ALS

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Biogen, Elan launch My MS Health, a web-based PRO research program

Biogen, Elan launch My MS Health, a web-based PRO research program

HPV-positive tumor status is strong prognostic factor for head, neck cancer

HPV-positive tumor status is strong prognostic factor for head, neck cancer

Aerovance reports top-line results from Aerovant Phase 2b clinical trial for eosinophilic asthma

Aerovance reports top-line results from Aerovant Phase 2b clinical trial for eosinophilic asthma

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Phase 2 study results of Qnexa in patients with OSA presented at SLEEP 2010

Phase 2 study results of Qnexa in patients with OSA presented at SLEEP 2010

FDA grants Cepheid marketing clearance for Xpert SA Nasal Complete molecular test

FDA grants Cepheid marketing clearance for Xpert SA Nasal Complete molecular test

UC-MSCT improves symptoms, biochemical values in patients with severe refractory SLE: Study

UC-MSCT improves symptoms, biochemical values in patients with severe refractory SLE: Study

USPTO grants ISCO patent to International Stem Cell's hpSC

USPTO grants ISCO patent to International Stem Cell's hpSC

Research project to transform primary care practices into patient-centered medical homes concludes

Research project to transform primary care practices into patient-centered medical homes concludes

Vitiligo associated with genes variations linked to body's immune response

Vitiligo associated with genes variations linked to body's immune response

New technology involving adipose stem cells may one day cure patients with severe wounds: Researchers

New technology involving adipose stem cells may one day cure patients with severe wounds: Researchers

Researchers compare clinical outcome of patients with smaller and larger AAAs after EVAR

Researchers compare clinical outcome of patients with smaller and larger AAAs after EVAR

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.